Suchergebnisse - "Antiviral Agents/therapeutic use"

Relink Programmes: Impact of Reengagement on Linkage to Care Across 82 006 People With Hepatitis C: Impact of Reengagement on Linkage to Care Across 82 006 People With Hepatitis C

Autoren: Maria Buti Joost P. H. Drenth Manuel Mendizabal et al.

Quelle: Liver International. 45

Schlagwörter: Male, Antiviral Agents/therapeutic use, Adult, lost to follow-up, Hepacivirus/genetics, Middle Aged, Viral/blood, chronic, Hepatitis C/diagnosis, Hepatitis C Antibodies/blood, antiviral agents, Humans, RNA, delivery of healthcare, Female, Prospective Studies, hepatitis C, Retrospective Studies, Program Evaluation, vulnerable populations

How COVID‐19 Treatment in Pregnancy Reflects Healthcare Utilization During a Pandemic: A Two‐Stage Individual Participant Data Meta‐Analysis Combining Case‐Based Registries: A Two-Stage Individual Participant Data Meta-Analysis Combining Case-Based Registries

Autoren: Emeline Maisonneuve Odette De Bruin Guillaume Favre et al.

Quelle: Pharmacoepidemiology and Drug Safety. 34

Schlagwörter: Adult, Antiviral Agents/therapeutic use, Infectious/drug therapy, Patient Acceptance of Health Care/statistics & numerical data, Registries/statistics & numerical data, CONSIGN group, medication use, COVID-19 Drug Treatment, Pregnancy Complications, Pregnancy, COVID‐19, meta‐analysis, Humans, Female, pregnancy, COVID-19/epidemiology, Hospitalization/statistics & numerical data

Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum

Autoren: Per Ljungman Roy F Chemaly Fareed Khawaya et al.

Weitere Verfasser: Per Ljungman Roy F Chemaly Fareed Khawaya et al.

Quelle: Clin Infect Dis
CLINICAL INFECTIOUS DISEASES
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Clinical infectious diseases, vol. 79, no. 3, pp. 787-794

Schlagwörter: 0301 basic medicine, Infectious Medicine, clinical trials, Clinical Trials as Topic, 0303 health sciences, Humans, Cytomegalovirus Infections/drug therapy, Cytomegalovirus Infections/virology, Cytomegalovirus Infections/diagnosis, Antiviral Agents/therapeutic use, Cytomegalovirus/drug effects, Transplant Recipients, Consensus, Drug Resistance, Viral, Organ Transplantation/adverse effects, CMV, disease definitions, organ transplantation, stem cell transplantation, Cytomegalovirus, Infektionsmedicin, Organ Transplantation, Antiviral Agents, 03 medical and health sciences, Cytomegalovirus Infections, Major Article

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39041385
https://incliva.fundanetsuite.com/publicaciones/ProdCientif/PublicacionFrw.aspx?id=18608
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_B2FFDC3344BC0
https://serval.unil.ch/notice/serval:BIB_B2FFDC3344BC
https://serval.unil.ch/resource/serval:BIB_B2FFDC3344BC.P001/REF.pdf
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-540608

Molécules pour traiter la grippe: vraiment utiles ?

Autoren: Bovey, F.

Quelle: Revue medicale suisse, vol. 21, no. 918, pp. 1053

Schlagwörter: Humans, Influenza, Human/drug therapy, Influenza, Human/epidemiology, Antiviral Agents/therapeutic use, Antiviral Agents/adverse effects, Dibenzothiepins/therapeutic use, Neuraminidase/antagonists & inhibitors, Oseltamivir/therapeutic use, Oseltamivir/adverse effects, Pyridones/therapeutic use, Morpholines, Triazines

Dateibeschreibung: application/pdf

Zugangs-URL: http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_F945594716D64
https://serval.unil.ch/notice/serval:BIB_F945594716D6
https://serval.unil.ch/resource/serval:BIB_F945594716D6.P001/REF.pdf

Human herpesvirus-6, HHV-8 and parvovirus B19 after allogeneic hematopoietic cell transplant: the lesser-known viral complications

Autoren: Kampouri, E. Little, J.S. Crocchiolo, R. et al.

Quelle: Curr Opin Infect Dis
Current opinion in infectious diseases, vol. 37, no. 4, pp. 245-253

Schlagwörter: Herpesvirus 6, Human, Hematopoietic Stem Cell Transplantation, Roseolovirus Infections, Herpesviridae Infections, Antiviral Agents, 3. Good health, Parvoviridae Infections, 03 medical and health sciences, Humans, Hematopoietic Stem Cell Transplantation/adverse effects, Herpesvirus 8, Human, Parvovirus B19, Human/isolation & purification, Parvoviridae Infections/epidemiology, Parvoviridae Infections/diagnosis, Antiviral Agents/therapeutic use, Roseolovirus Infections/epidemiology, Roseolovirus Infections/virology, Roseolovirus Infections/diagnosis, Transplantation, Homologous/adverse effects, Herpesviridae Infections/epidemiology, Herpesviridae Infections/virology, 0302 clinical medicine, Parvovirus B19, Human, INFECTIONS OF THE IMMUNOCOMPROMISED HOST: Edited by Genovefa Papanicolaou and Dionysios Neofytos, Transplantation, Homologous

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38726832
https://serval.unil.ch/notice/serval:BIB_5CFB1FC80B66
https://serval.unil.ch/resource/serval:BIB_5CFB1FC80B66.P001/REF.pdf
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_5CFB1FC80B665

Herpes zoster in Belgium: a new solution to an old problem

Autoren: Nikkels, Arjen Schoevaerdts, Didier Kauffmann, Florence et al.

Weitere Verfasser: Nikkels, Arjen Schoevaerdts, Didier Kauffmann, Florence et al.

Quelle: Acta clinica Belgica, Vol. 79, no. 3, p. 205-216 (2024)

Schlagwörter: Neuralgia, Postherpetic/epidemiology, Herpes Zoster/drug therapy, Herpes zoster, Neuralgia, Postherpetic, Dermatology, Sciences de la santé humaine, Herpes Zoster, Antiviral Agents, Immunocompromised Host, Belgium, Neuralgia, Postherpetic/drug therapy, Herpes Zoster/prevention & control, Humans, Herpes Zoster Vaccine, Human health sciences, Belgium/epidemiology, Aged, Antiviral Agents/therapeutic use, Dermatologie, Medicine (all), Middle Aged, vaccination, Neuralgia, Postherpetic/prevention & control, 3. Good health, recombinant zoster vaccine, Herpes Zoster/epidemiology, epidemiology

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38781037
https://hdl.handle.net/2268/335576
https://doi.org/10.1080/17843286.2024.2350258
https://hdl.handle.net/2078.1/287688

SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir

Autoren: Kanal Singh Kevin Rubenstein Viviane Callier et al.

Weitere Verfasser: Kanal Singh Kevin Rubenstein Viviane Callier et al.

Quelle: Singh, K, Rubenstein, K, Callier, V, Shaw-Saliba, K, Rupert, A, Dewar, R, Laverdure, S, Highbarger, H, Lallemand, P, Huang, M-L, Jerome, K R, Sampoleo, R, Mills, M G, Greninger, A L, Juneja, K, Porter, D, Benson, C A, Dempsey, W, El Sahly, H M, Focht, C, Jilg, N, Paules, C I, Rapaka, R R, Uyeki, T M, Lane, H C, Beigel, J, Dodd, L E, Adaptive COVID-19 Treatment Trial (ACTT-1) Study Group Members & Nielsen, H 2024, 'SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir', The Journal of Infectious Diseases, vol. 230, no. 3, jiae198, pp. 624-634. https://doi.org/10.1093/infdis/jiae198
The Journal of Infectious Diseases, vol 230, iss 3
Singh, K, Rubenstein, K, Callier, V, Shaw-Saliba, K, Rupert, A, Dewar, R, Laverdure, S, Highbarger, H, Lallemand, P, Huang, M-L, Jerome, K R, Sampoleo, R, Mills, M G, Greninger, A L, Juneja, K, Porter, D, Benson, C A, Dempsey, W, El Sahly, H M, Focht, C, Jilg, N, Paules, C I, Rapaka, R R, Uyeki, T M, Lane, H C, Beigel, J, Dodd, L E & Adaptive COVID-19 Treatment Trial (ACTT-1) Study Group Members 2024, 'SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir', The Journal of Infectious Diseases, vol. 230, no. 3, pp. 624-634. https://doi.org/10.1093/infdis/jiae198

Schlagwörter: Male, Adult, 0301 basic medicine, COVID-19/blood, remdesivir, antiviral efficacy, Antiviral Agents, Adenosine Monophosphate/analogs & derivatives, Coronavirus Nucleocapsid Proteins/immunology, SARS-CoV-2/immunology, 03 medical and health sciences, 0302 clinical medicine, Humans, Coronavirus Nucleocapsid Proteins, Viral, RNA, Viral/blood, Antigens, Antigens, Viral, Aged, Antiviral Agents/therapeutic use, Alanine, SARS-CoV-2, COVID-19, clinical trial, Alanine/analogs & derivatives, antiviral efficacy, clinical trial, COVID-19, remdesivir, SARS-CoV-2, Middle Aged, Viral Load, Adenosine Monophosphate, COVID-19 Drug Treatment, 3. Good health, Antigens, Viral/blood, Treatment Outcome, RNA, RNA, Viral, Female, Biomarkers/blood, Biomarkers

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38657001
https://vbn.aau.dk/da/publications/848d0595-5d78-4048-abfa-86e65c031503
https://doi.org/10.1093/infdis/jiae198
http://www.scopus.com/inward/record.url?scp=85204819223&partnerID=8YFLogxK
https://vbn.aau.dk/ws/files/705491966/Singh_et_al._2024_._SARS-CoV-2_RNA_and_nucleocapsid_antigen_are_blood_biomarkers_associated_with_severe_disease_outcomes_that_improve_in_response_to_remdesivir.pdf
https://escholarship.org/content/qt2hf3r271/qt2hf3r271.pdf
https://escholarship.org/uc/item/2hf3r271

CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged ≥ 28 Days and ≤ 3 Years with Acute Respiratory Tract Infection Due to Respiratory Syncytial Virus

Autoren: Ferrero, Fernando Lin, Chien-Yu Liese, Johannes et al.

Quelle: Paediatr Drugs

Schlagwörter: Male, ddc:610, Dose-Response Relationship, Drug, Infant, Newborn, Infant, Respiratory Syncytial Virus Infections, Viral Load, Antiviral Agents, Dose-Response Relationship, Drug [MeSH], Infant, Newborn [MeSH], Double-Blind Method [MeSH], Female [MeSH], Viral Load/drug effects [MeSH], Antiviral Agents/adverse effects [MeSH], Humans [MeSH], Antiviral Agents/pharmacokinetics [MeSH], Treatment Outcome [MeSH], Infant [MeSH], Male [MeSH], Antiviral Agents/administration, Antiviral Agents/therapeutic use [MeSH], Original Research Article, Respiratory Tract Infections/virology [MeSH], Respiratory Tract Infections/drug therapy [MeSH], Respiratory Syncytial Virus Infections/drug therapy [MeSH], Child, Preschool [MeSH], Treatment Outcome, Double-Blind Method, Child, Preschool, Humans, Female, Respiratory Tract Infections

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38649595
https://repository.publisso.de/resource/frl:6518302
https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/39743
https://opus.bibliothek.uni-wuerzburg.de/files/39743/40272_2024_Article_625.pdf
https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-397438
https://doi.org/10.1007/s40272-024-00625-x

Assessing the Burden of Respiratory Syncytial Virus-related Bronchiolitis in Primary Care and at 15-Day and 6-Month Follow-up Before Prophylaxis in France: A Test-negative Study

Autoren: Alexis Rybak Robert Cohen Mathieu Bangert et al.

Quelle: Pediatr Infect Dis J
The Pediatric infectious disease journal, vol. 43, no. 7, pp. 657-662

Schlagwörter: Male, Primary Health Care, Infant, Newborn, Infant, Respiratory Syncytial Virus Infections, Antiviral Agents, Original Studies, 03 medical and health sciences, 0302 clinical medicine, Cost of Illness, Humans, Respiratory Syncytial Virus Infections/epidemiology, Respiratory Syncytial Virus Infections/prevention & control, France/epidemiology, Primary Health Care/statistics & numerical data, Female, Prospective Studies, Quality of Life, Follow-Up Studies, Respiratory Syncytial Virus, Human, Bronchiolitis/virology, Bronchiolitis/epidemiology, Surveys and Questionnaires, Antiviral Agents/therapeutic use, Bronchiolitis, France

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38900603
https://serval.unil.ch/resource/serval:BIB_78D329972D16.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_78D329972D16
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_78D329972D166

Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients

Autoren: Vernooij, Robin Wm Michael, Mini Colombijn, Julia Mt et al.

Weitere Verfasser: Vernooij, Robin Wm Michael, Mini Colombijn, Julia Mt et al.

Quelle: Cochrane Database of Systematic Reviews. 2025

Schlagwörter: Antiviral Agents/therapeutic use, Organ Transplantation/adverse effects, Cytomegalovirus Infections/prevention & control, Postoperative Complications/prevention & control, Cytomegalovirus, Review, Organ Transplantation, Antiviral Agents, Transplant Recipients, Bias, Ganciclovir/therapeutic use, Cytomegalovirus Infections, Journal Article, Humans, Valganciclovir, Viremia, Viremia/prevention & control, Ganciclovir, Meta-Analysis, Randomized Controlled Trials as Topic

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39807668
https://dspace.library.uu.nl/handle/1874/460120

Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19

Autoren: Neil R Aggarwal Jacquie Nordwall Dominique L Braun et al.

Weitere Verfasser: Neil R Aggarwal Jacquie Nordwall Dominique L Braun et al.

Quelle: Aggarwal, N R, Nordwall, J, Braun, D L, Chung, L, Coslet, J, Der, T, Eriobu, N, Ginde, A A, Hayanga, A J, Highbarger, H, Holodniy, M, Horcajada, J P, Jain, M K, Kim, K, Laverdure, S, Lundgren, J, Natarajan, V, Nguyen, H H, Pett, S L, Phillips, A, Poulakou, G, Price, D A, Robinson, P, Rogers, A J, Sandkovsky, U, Shaw-Saliba, K, Sturek, J M, Trautner, B W, Waters, M, Reilly, C, ACTIV-3/TICO Study Group, Nielsen, H, Thisted, R K, Petersen, K T & Juhl, M R 2024, 'Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19', Clinical Infectious Diseases, vol. 78, no. 6, ciad780, pp. 1490-1503. https://doi.org/10.1093/cid/ciad780
Clinical Infectious Diseases, vol 78, iss 6

Schlagwörter: Microbiology (medical), Male, Adult, 0301 basic medicine, Medical Sciences, Epidemiology, 610 Medicine & health, Antibodies, Viral, 142-005 142-005, Antiviral Agents, Antibodies, 10234 Clinic for Infectious Diseases, 03 medical and health sciences, Antibodies, Viral/blood, acute COVID-19, Medical Specialties, Medicine and Health Sciences, host response, Humans, Clinical Epidemiology, Viral, RNA, Viral/blood, Antigens, Antigens, Viral, viral factors, Aged, Antiviral Agents/therapeutic use, COVID-19/mortality, 0303 health sciences, SARS-CoV-2, Interleukin-6, COVID-19, Middle Aged, COVID-19 Drug Treatment, 3. Good health, Antigens, Viral/blood, Hospitalization, Infectious Diseases, Acute COVID-19, RNA, RNA, Viral, Female, Public Health, Interleukin-6/blood

Dateibeschreibung: application/pdf; ciad780.pdf - application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38376212
https://vbn.aau.dk/da/publications/e9c0cb99-dc7d-4c62-bd40-6881b1a6c2d4
https://doi.org/10.1093/cid/ciad780
http://www.scopus.com/inward/record.url?scp=85191029545&partnerID=8YFLogxK
https://pergamos.lib.uoa.gr/uoa/dl/object/3483684
https://discovery-pp.ucl.ac.uk/id/eprint/10188073/
https://escholarship.org/uc/item/232910xd
https://escholarship.org/content/qt232910xd/qt232910xd.pdf
https://www.zora.uzh.ch/id/eprint/258807/
https://doi.org/10.5167/uzh-258807

Les atteintes ORL de l’infection ­congénitale à cytomégalovirus

Autoren: Lambiel, Silvia L'Huillier, Arnaud Perez Fornos, Angelica et al.

Quelle: Revue Médicale Suisse. 20:1742-1746

Schlagwörter: 616.8, Antiviral Agents / therapeutic use, Infant, Newborn, Vestibular Diseases / diagnosis, Pregnancy Complications, Infectious / diagnosis, Cytomegalovirus Infections / congenital, Hearing Loss, Sensorineural / virology, Vestibular Diseases / etiology, Cytomegalovirus Infections / complications, Vestibular Diseases / epidemiology, Pregnancy, Hearing Loss, Sensorineural / etiology, Humans, Female, Hearing Loss, Sensorineural / diagnosis, Hearing Loss, Sensorineural / epidemiology, Cytomegalovirus Infections / diagnosis

Dateibeschreibung: application/pdf

Zugangs-URL: https://archive-ouverte.unige.ch/unige:182897
https://doi.org/10.53738/revmed.2024.20.889.1742

Clinical phenotype and outcome of persistent SARS-CoV-2 replication in immunocompromised hosts: a retrospective observational study in the Omicron era

Autoren: Götz, Veronika Mathé, Philipp Agarwal, Prerana et al.

Quelle: Infection

Schlagwörter: Male, Adult, Aged, 80 and over, SARS-CoV-2, Research, COVID-19, Middle Aged, Viral Load, Virus Replication, Antiviral Agents, COVID-19 Drug Treatment, 3. Good health, Immunocompromised Host, Phenotype, Treatment Outcome, Humans, Female, COVID-19/immunology [MeSH], Aged, 80 and over [MeSH], Viral Load/drug effects [MeSH], Aged [MeSH], Virus Replication [MeSH], COVID-19 Drug Treatment [MeSH], Antiviral therapy, Male [MeSH], Fibrotic-like lung changes, COVID-19/physiopathology [MeSH], Phenotype [MeSH], SARS-CoV-2 [MeSH], COVID-19/diagnosis [MeSH], Female [MeSH], COVID-19/virology [MeSH], Adult [MeSH], Humans [MeSH], Immunocompromised Host [MeSH], Treatment Outcome [MeSH], Retrospective Studies [MeSH], Omicron, Middle Aged [MeSH], Immunosuppression, Lower respiratory tract, Antiviral Agents/therapeutic use [MeSH], Retrospective Studies, Aged

Dateibeschreibung: pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38095753
https://repository.publisso.de/resource/frl:6493504

Monitoring of over-the-counter (OTC) and COVID-19 treatment drugs complement wastewater surveillance of SARS-CoV-2

Autoren: Cheng-Shiuan Lee Mian Wang Deepak Nanjappa et al.

Quelle: J Expo Sci Environ Epidemiol
Journal of Exposure Science & Environmental Epidemiology

Schlagwörter: Wastewater-Based Epidemiological Monitoring, Alanine, SARS-CoV-2, COVID-19, Nonprescription Drugs, Bayes Theorem, Chloroquine, Wastewater, Wastewater-based epidemiology, Hydroxychloroquine/therapeutic use [MeSH], Wastewater-Based Epidemiological Monitoring [MeSH], Bayes Theorem [MeSH], COVID-19 Drug Treatment [MeSH], RNA, Viral/analysis [MeSH], Acetaminophen, Chloroquine/therapeutic use [MeSH], Antiviral Agents/analysis [MeSH], Alanine/analogs, Nonprescription Drugs/therapeutic use [MeSH], COVID-19/epidemiology [MeSH], SARS-CoV-2 [MeSH], Bayesian models, Remdesivir, Alanine/therapeutic use [MeSH], Humans [MeSH], Adenosine Monophosphate/analogs, Adenosine Monophosphate/therapeutic use [MeSH], Chloroquine/analysis [MeSH], Article, COVID-19 pandemic, Wastewater/virology [MeSH], Antiviral Agents/therapeutic use [MeSH], article, Antiviral Agents, Adenosine Monophosphate, 6. Clean water, COVID-19 Drug Treatment, 3. Good health, 13. Climate action, Humans, RNA, Viral, Hydroxychloroquine

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/38052940
http://hdl.handle.net/21.11116/0000-000E-1131-7
http://hdl.handle.net/21.11116/0000-000E-1133-5
https://repository.publisso.de/resource/frl:6518839

Long‐term trends in hepatitis C prevalence, treatment uptake and liver‐related events in the Swiss HIV Cohort Study

Autoren: Baumann, Lukas Braun, Dominique L Cavassini, Matthias et al.

Weitere Verfasser: Baumann, Lukas Braun, Dominique L Cavassini, Matthias et al.

Quelle: Liver international, vol. 44, no. 1, pp. 169-179
Baumann, Lukas; Braun, Dominique L; Cavassini, Matthias; Stoeckle, Marcel; Bernasconi, Enos; Schmid, Patrick; Calmy, Alexandra; Haerry, David; Béguelin, Charles; Fux, Christoph A; Wandeler, Gilles; Surial, Bernard; Rauch, Andri (2024). Long-term trends in hepatitis C prevalence, treatment uptake and liver-related events in the Swiss HIV Cohort Study. Liver international, 44(1), pp. 169-179. Wiley 10.1111/liv.15754 <http://dx.doi.org/10.1111/liv.15754>

Schlagwörter: 10028 Institute of Medical Virology, Male, 610 Medicine & health, HIV Infections, Hepacivirus, Humans, Prevalence, Cohort Studies, Homosexuality, Male, Hepatitis C, Chronic/drug therapy, Hepatitis C, Chronic/epidemiology, Hepatitis C, Chronic/complications, Antiviral Agents/therapeutic use, Switzerland/epidemiology, Drug Users, HIV Infections/drug therapy, HIV Infections/epidemiology, HIV Infections/complications, Substance Abuse, Intravenous/complications, Substance Abuse, Intravenous/epidemiology, Sexual and Gender Minorities, Hepatitis C/drug therapy, Hepatitis C/epidemiology, Hepatitis C/complications, Hepacivirus/genetics, Coinfection/drug therapy, RNA, DAA, HCV, HIV, HIV coinfection, hepatitis C, hepatitis C treatment outcomes, Antiviral Agents, 10234 Clinic for Infectious Diseases, Substance Abuse, Intravenous, Coinfection, Hepatitis C, Chronic, Hepatitis C, 3. Good health, 2721 Hepatology, Switzerland

Dateibeschreibung: application/pdf; Liver_International___2023___Baumann___Long_term_trends_in_hepatitis_C_prevalence_treatment_uptake_and_liver_related.pdf - application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/37850685
https://serval.unil.ch/resource/serval:BIB_67D0635AAB87.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_67D0635AAB87
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_67D0635AAB879
https://boris.unibe.ch/187288/

Long‐term quantitative hepatitis B surface antigen (HBsAg) trajectories in persons with and without HBsAg loss on tenofovir‐containing antiretroviral therapy

Autoren: Begré, Lorin Boyd, Anders Salazar‐Vizcaya, Luisa et al.

Weitere Verfasser: Begré, Lorin Boyd, Anders Salazar‐Vizcaya, Luisa et al.

Quelle: HIV medicine, vol. 25, no. 2, pp. 291-298
HIV Medicine

Schlagwörter: Hepatitis B Surface Antigens, HIV, HIV Infections, 16. Peace & justice, Antiviral Agents, tenofovir, 3. Good health, Cohort Studies, HBsAg, Hepatitis B, Chronic, Humans, Tenofovir/therapeutic use, Hepatitis B Surface Antigens/therapeutic use, Antiviral Agents/therapeutic use, HIV Infections/drug therapy, Hepatitis B, Chronic/drug therapy, Hepatitis B e Antigens/therapeutic use, DNA, Viral, hepatitis B, trajectories, Hepatitis B e Antigens, Tenofovir

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/37816492
https://serval.unil.ch/notice/serval:BIB_575061651828
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_5750616518283
https://serval.unil.ch/resource/serval:BIB_575061651828.P001/REF.pdf

HBV reactivation in patients with rheumatoid arthritis treated with anti-interleukin-6: a systematic review and meta-analysis

Autoren: Stamatia Katelani George E Fragoulis Athanasios-Dimitrios Bakasis et al.

Quelle: Rheumatology (Oxford)
Katelani, S, Fragoulis, G E, Bakasis, A-D, Pouliakis, A, Nikiphorou, E, Atzeni, F & Androutsakos, T 2023, ' HBV reactivation in patients with rheumatoid arthritis treated with anti-interleukin-6 : a systematic review and meta-analysis ', Rheumatology, vol. 62, no. SI3, pp. SI252-SI259 . https://doi.org/10.1093/rheumatology/kead243

Schlagwörter: Antiviral Agents/therapeutic use, Arthritis, Rheumatoid, Hepatitis B virus, Arthritis, Rheumatoid/drug therapy, Arthritis, Humans, Virus Activation, Review, Child, Antiviral Agents, 3. Good health, Rheumatoid/drug therapy

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/37871924
https://pergamos.lib.uoa.gr/uoa/dl/object/3499765
https://kclpure.kcl.ac.uk/ws/files/241621641/RHE-23-0462.R1_Proof_hi.pdf

Immune-Mediated Hemolytic Anemia in Cats with Feline Infectious Peritonitis

Autoren: Černá, Petra Knies, Marieke Assink, Marleen et al.

Weitere Verfasser: Černá, Petra Knies, Marieke Assink, Marleen et al.

Quelle: Pathogens
Pathogens, Vol 14, Iss 7, p 660 (2025)

Schlagwörter: Antiviral Agents/therapeutic use, Glucocorticoids/therapeutic use, Male, FIP, PIMA, Feline/immunology, coronavirus, 610 Medicine & health, Anemia, Article, Coronavirus, Autoimmune/veterinary, IMHA, 11404 Department of Clinical Diagnostics and Services, Cats, Animals, Feline Infectious Peritonitis/complications, Medicine, Female, 11434 Center for Clinical Studies, Hemolytic

Dateibeschreibung: pathogens_14_00660.pdf - application/pdf

Zugangs-URL: https://doaj.org/article/bfb5e4e8c817477987c0df9ae43ee93e
https://www.zora.uzh.ch/id/eprint/279163/
https://doi.org/10.5167/uzh-279163

How COVID-19 Treatment in Pregnancy Reflects Healthcare Utilization During a Pandemic : A Two-Stage Individual Participant Data Meta-Analysis Combining Case-Based Registries

Autoren: Maisonneuve, Emeline De Bruin, Odette Favre, Guillaume et al.

Quelle: ISSN: 1053-8569 ; Pharmacoepidemiology and drug safety, vol. 34, no. 7 (2025) e70180.

Schlagwörter: info:eu-repo/classification/ddc/618, CONSIGN group, COVID‐19, Medication use, Meta‐analysis, Pregnancy, Humans, Female, Registries / statistics & numerical data, Pregnancy Complications, Infectious / drug therapy, Infectious / epidemiology, COVID-19 Drug Treatment, COVID-19 / epidemiology, COVID-19 / therapy, Hospitalization / statistics & numerical data, Patient Acceptance of Health Care / statistics & numerical data, Antiviral Agents / therapeutic use, Adult

Relation: info:eu-repo/semantics/altIdentifier/pmid/40665803; unige:189086

Verfügbarkeit: https://archive-ouverte.unige.ch/unige:189086

Prenatal Screening for CMV Primary Infection : A Cost-Utility Model

Autoren: El Hachem, Gebrael Poder, Thomas G Mc Carey, Catherine Grazia et al.

Quelle: ISSN: 1470-0328 ; BJOG, vol. 132, no. 6 (2025) p. 805-815.

Schlagwörter: Cost utility, Cytomegalovirus, Prenatal screening, Humans, Female, Pregnancy, Cytomegalovirus Infections / economics, Cytomegalovirus Infections / diagnosis, Cytomegalovirus Infections / prevention & control, Cytomegalovirus Infections / congenital, Cost-Benefit Analysis, Pregnancy Complications, Infectious / diagnosis, Infectious / economics, Quality-Adjusted Life Years, Prenatal Diagnosis / economics, Prenatal Diagnosis / methods, Canada, Pregnancy Trimester, First, Antiviral Agents / therapeutic use, Antiviral Agents / economics, Infectious Disease Transmission, Vertical / prevention & control, Vertical / economics, Infant, Newborn

Relation: info:eu-repo/semantics/altIdentifier/pmid/39895506; unige:188863

Verfügbarkeit: https://archive-ouverte.unige.ch/unige:188863